Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Next-generation T-cells-plattform for precision immunomonitoring of autoimmune diseases

Reference number
Coordinator NEOGAP Therapeutics AB
Funding from Vinnova SEK 200 000
Project duration October 2025 - April 2026
Status Ongoing
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: Competence Enhancement in Small Businesses 2025

Purpose and goal

The aim with this project is to: a) conduct market research b) identify stakeholders and potential partners c) establish product and marketing materials d) develop an evidence generation plan The goal is to increase our knowledge of the market, target audience, competition and users´ unmet needs in preparation for a successful market introduction.

Expected effects and result

We expect a clearer and updated picture of the market, including insights into competition, customer segments and current trends in the field, as well as an evidence generation plan. Based on the outcomes of this project we plan to conduct a product validation in collaboration with key opinion leaders to strengthen the evidence for the reliability and benefit of the platform. This will in turn improve our strategic positioning and increase the chances of a successful market introduction.

Planned approach and implementation

The project includes the development of product and marketing materials as well as the planning and implementation of a market study in aim to ensure that the product´s value proposition is relevant to the target group. The work results in a presentation material (slide deck) that can be used in dialogue with the market, investors, partners and customers, as well as a compilation of methods and results from the conducted market study.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 22 October 2025

Reference number 2025-02928